Neurocrine Biosciences (NBIX) Tops Q1 EPS by 29c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $156.22 -0.22%
Revenue Growth %: +30.8%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: +30.8%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of ($0.01), $0.29 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
- Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
